Delivery Order SPE2DB24D6041-SPE2DB25FKBJP

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,149,251 units of Epinephrine 0.3 mg auto-injectors on a firm-fixed price basis. The $1,224.96 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract has an ultimate completion date of October 21, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,562,163,672 units of Epinephrine 0.3 mg auto-injectors, awarded to AmerisourceBergen Drug Corp. The $5,053.63 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 14, 2023. This appears to be a child contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,565,321,570 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, with a ceiling value of $3,674.88. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,557,370,375 Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC is a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of 4,560,408,165 units of epinephrine 0.15 mg auto-injectors. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on March 28, 2023. The contract is a delivery order with a firm-fixed price and a ceiling value of $1,196.24. It has an ultimate completion date of March 29, 2023 and is not designated as a set-aside contract. This award is...
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00 Indefinite...
This federal contract award is for the delivery of 4,566,929,491 units of epinephrine 0.3 mg auto-injectors over a period ending on January 15, 2025. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,033.50 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,566,708,687 units of epinephrine 0.3 mg auto-injectors. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,642.89. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,566,250,569 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $7,709.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside...
This federal contract award is for the delivery of 4,564,260 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,990.60 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for up to $999,999,999.00 through December...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBJP
    Delivery Order

This federal contract award, with ID SPE2DB24D6041|SPE2DB25FKBJP, is for the delivery of 4,566,270,771 units of Epinephrine 0.3 mg auto-injectors. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024, with a ceiling value of $4,028.40. The contract is a Delivery Order under a Firm Fixed Price contract type, with an ultimate completion date of October 31, 2024.

The contracting agency is the Defense Logistics Agency (DLA), a defense agency that supports the military's logistics needs. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 1/29/25, 9:08 AM